Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Carter

Showing results (991-1000 of 1,023) with videos related to

Pageof 103
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50J F Gainor, H Rizvi, E Jimenez Aguilar, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Journal for Immunotherapy of Cancer|July 4, 2023
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trialMehmet Altan, Yan Wang, Juhee Song, et al.
Molecular Psychiatry|October 5, 2011
Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophreniaA Jablensky, D Angelicheva, G J Donohoe, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Cancer Cell|July 12, 2022
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivityYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2019
Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology DatabasesAnja C Roden, Wentao Fang, Yan Shen, et al.
Cancer Letters|June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center StudyAmgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.
Cancers|November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible PatientsMorteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Pageof 103

Showing results (991-1000 of 1,023) with videos related to

Sort By:
Pageof 103
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50J F Gainor, H Rizvi, E Jimenez Aguilar, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Journal for Immunotherapy of Cancer|July 4, 2023
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trialMehmet Altan, Yan Wang, Juhee Song, et al.
Molecular Psychiatry|October 5, 2011
Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophreniaA Jablensky, D Angelicheva, G J Donohoe, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Cancer Cell|July 12, 2022
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivityYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 25, 2019
Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology DatabasesAnja C Roden, Wentao Fang, Yan Shen, et al.
Cancer Letters|June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center StudyAmgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.
Cancers|November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible PatientsMorteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Pageof 103